Image of Injections

Welcome to King Guide Publications
True. Tested. Experienced.

King® Guide to Parenteral Admixtures®

Consistency Counts

2016 marks the 45th year that the King Guide to Parenteral Admixtures has been the leading source of the most up-to-date IV drug compatibility and stability information in hospital pharmacy practice worldwide.  In those 45 years, Dr. James King and Dr. Patrick Catania have been the only editors of the King Guide and have made carefully crafted updates every quarter using painstaking and time-tested methods for data collection and reporting. No other references can claim this kind of consistency in information compilation.

Well Informed Decisions

Drug safety, improved patient outcomes, ensuring compliance and eliminating costly errors have always been our top priorities. Using the latest technology and a consistent editorial team benefits practitioners' ability to analyze continuously updated information without sacrificing convenience and mobility.

Transparency Matters

At King Guide, we believe everyone is entitled to know exactly what new and updated information goes into our reference. No other injectable drug compatibility reference on the market offers this level of transparency, making it difficult to determine the quantity and quality of the work they produce.

In 2017, we added...

17 New Drugs
New Compatibility Information for 263 Drugs
New Stability Information for 44 Drugs
A complete list of our updates is available on our news & updates page.

We invite you to compare "What's In Your Database?" and offer a free trial for your analysis.

Peer Reviewed, Evidence Based

We strive to include in the King Guide to Parenteral Admixtures only that information which has been published in peer reviewed and refereed journals or information that is provided by the manufacturer. We believe that by using only data that have been reviewed via the professional literature, we insure the accuracy of the content of King Guide. Unpublished results that have not had the benefit of scholarly review are inadequate and other references that rely heavily on unpublished results should be scrutinized cautiously.

Online Edition

System wide access to our database makes decision making available where it's needed most - at the point of care.  We invite you to take a look for yourself by requesting a free trial.

IV Compatibility Wall Charts

JCAHO endorsed, our wall charts are ideal for nurses stations and are available in laminate for extra durability.

Print Edition

The original King Guide and still the best way to maintain rapidly changing information in print. Popular in facilities where technology isn't always available or when an offline resource is required.

Database Licensing

For HIT vendors and hospitals. Add significant value to existing systems by incorporating the King Guide Database.

New for Winter 2017

In this update we added new stability information for the existing drug monograph for TENECTEPLASE. In addition, new compatibility information is reported for these existing monographs:  MORPHINE SULFATE, ROPIVACAINE HYDROCHLORIDE, and ZICONOTIDE; COLISTIMETHATE SODIUM WITH ERTAPENEM, IMIPENEM-CILASTATIN SODIUM, LINEZOLID, MEROPENEM, PIPERACILLIN AND TAZOBACTAM, and VANCOMYCIN HYDROCHLORIDE; and ISAVUCONAZONIUM SULFATE with 95 other drugs.
View past updates